Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (151-160 of 403) with videos related to

Pageof 41
Sort By:
Vaccine|March 23, 2005
Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine in toddlers and school childrenJamie Findlow, Ann Lowe, Sarah Deane, et al.
Clinical and Vaccine Immunology : CVI|September 21, 2007
Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccinePaul Balmer, Ray Borrow, Jamie Findlow, et al.
Vaccine|October 2, 2012
Immunity to tetanus and diphtheria in the UK in 2009Karen S Wagner, Joanne M White, Nick J Andrews, et al.
Plos One|January 26, 2016
Characteristic Cytokine and Chemokine Profiles in Encephalitis of Infectious, Immune-Mediated, and Unknown AetiologyBenedict D Michael, Michael J Griffiths, Julia Granerod, et al.
Human Vaccines & Immunotherapeutics|November 13, 2024
Exploring the sequence diversity and surface expression of Factor H-Binding Protein among invasive serogroup B meningococcal strains from selected European countriesStephen A Clark, Laura Willerton, Heike Claus, et al.
The Journal of Infectious Diseases|October 29, 2002
Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdomRay Borrow, David Goldblatt, Nick Andrews, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 13, 2019
Suspected cluster of <i>Neisseria meningitidis</i> W invasive disease in an elderly care home: do new laboratory methods aid public health action? United Kingdom, 2015Jonathan Lawler, Jay Lucidarme, Sydel Parikh, et al.
Plos One|December 14, 2011
Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and WalesNick Andrews, Pauline A Waight, Ray Borrow, et al.
Infection and Immunity|September 10, 2008
Serotype-specific immune unresponsiveness to pneumococcal conjugate vaccine following invasive pneumococcal diseaseRay Borrow, Elaine Stanford, Pauline Waight, et al.
Clinical and Vaccine Immunology : CVI|March 13, 2009
Evidence of a functional B-cell immunodeficiency in adults who experience serogroup C meningococcal diseaseRachel A Foster, Jennifer Carlring, Michael W McKendrick, et al.
Pageof 41

Showing results (151-160 of 403) with videos related to

Sort By:
Pageof 41
Vaccine|March 23, 2005
Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine in toddlers and school childrenJamie Findlow, Ann Lowe, Sarah Deane, et al.
Clinical and Vaccine Immunology : CVI|September 21, 2007
Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccinePaul Balmer, Ray Borrow, Jamie Findlow, et al.
Vaccine|October 2, 2012
Immunity to tetanus and diphtheria in the UK in 2009Karen S Wagner, Joanne M White, Nick J Andrews, et al.
Plos One|January 26, 2016
Characteristic Cytokine and Chemokine Profiles in Encephalitis of Infectious, Immune-Mediated, and Unknown AetiologyBenedict D Michael, Michael J Griffiths, Julia Granerod, et al.
Human Vaccines & Immunotherapeutics|November 13, 2024
Exploring the sequence diversity and surface expression of Factor H-Binding Protein among invasive serogroup B meningococcal strains from selected European countriesStephen A Clark, Laura Willerton, Heike Claus, et al.
The Journal of Infectious Diseases|October 29, 2002
Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdomRay Borrow, David Goldblatt, Nick Andrews, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 13, 2019
Suspected cluster of <i>Neisseria meningitidis</i> W invasive disease in an elderly care home: do new laboratory methods aid public health action? United Kingdom, 2015Jonathan Lawler, Jay Lucidarme, Sydel Parikh, et al.
Plos One|December 14, 2011
Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and WalesNick Andrews, Pauline A Waight, Ray Borrow, et al.
Infection and Immunity|September 10, 2008
Serotype-specific immune unresponsiveness to pneumococcal conjugate vaccine following invasive pneumococcal diseaseRay Borrow, Elaine Stanford, Pauline Waight, et al.
Clinical and Vaccine Immunology : CVI|March 13, 2009
Evidence of a functional B-cell immunodeficiency in adults who experience serogroup C meningococcal diseaseRachel A Foster, Jennifer Carlring, Michael W McKendrick, et al.
Pageof 41